These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32031745)

  • 1. Shielding islets with human amniotic epithelial cells enhances islet engraftment and revascularization in a murine diabetes model.
    Lebreton F; Bellofatto K; Wassmer CH; Perez L; Lavallard V; Parnaud G; Cottet-Dumoulin D; Kerr-Conte J; Pattou F; Bosco D; Othenin-Girard V; Martinez de Tejada B; Berishvili E
    Am J Transplant; 2020 Jun; 20(6):1551-1561. PubMed ID: 32031745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioengineered human pseudoislets form efficiently from donated tissue, compare favourably with native islets in vitro and restore normoglycaemia in mice.
    Yu Y; Gamble A; Pawlick R; Pepper AR; Salama B; Toms D; Razian G; Ellis C; Bruni A; Gala-Lopez B; Lu JL; Vovko H; Chiu C; Abdo S; Kin T; Korbutt G; Shapiro AMJ; Ungrin M
    Diabetologia; 2018 Sep; 61(9):2016-2029. PubMed ID: 29971529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Immunomodulation and Cytoprotection Conferred to Pancreatic Islet by Human Amniotic Epithelial Cells.
    Lebreton F; Hanna R; Wassmer CH; Bellofatto K; Perez L; Othenin-Girard V; de Tejada BM; Cohen M; Berishvili E
    Stem Cell Rev Rep; 2022 Jan; 18(1):346-359. PubMed ID: 34613550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMX-001, a novel redox-active metalloporphyrin, improves islet function and engraftment in a murine transplant model.
    Bruni A; Pepper AR; Pawlick RL; Gala-Lopez B; Gamble A; Kin T; Malcolm AJ; Jones C; Piganelli JD; Crapo JD; Shapiro AMJ
    Am J Transplant; 2018 Aug; 18(8):1879-1889. PubMed ID: 29464912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes.
    Lebreton F; Lavallard V; Bellofatto K; Bonnet R; Wassmer CH; Perez L; Kalandadze V; Follenzi A; Boulvain M; Kerr-Conte J; Goodman DJ; Bosco D; Berney T; Berishvili E
    Nat Commun; 2019 Oct; 10(1):4491. PubMed ID: 31582751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of encapsulating and microporous nondegradable hydrogel scaffold designs on islet engraftment in rodent models of diabetes.
    Rios PD; Skoumal M; Liu J; Youngblood R; Kniazeva E; Garcia AJ; Shea LD
    Biotechnol Bioeng; 2018 Sep; 115(9):2356-2364. PubMed ID: 29873059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engraftment Site and Effectiveness of the Pan-Caspase Inhibitor F573 to Improve Engraftment in Mouse and Human Islet Transplantation in Mice.
    Pepper AR; Bruni A; Pawlick R; Wink J; Rafiei Y; Gala-Lopez B; Bral M; Abualhassan N; Kin T; Shapiro AMJ
    Transplantation; 2017 Oct; 101(10):2321-2329. PubMed ID: 28072753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined transplantation of pancreatic islets and adipose tissue-derived stem cells enhances the survival and insulin function of islet grafts in diabetic mice.
    Ohmura Y; Tanemura M; Kawaguchi N; Machida T; Tanida T; Deguchi T; Wada H; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Matsuura N; Ito T; Nagano H; Doki Y; Mori M
    Transplantation; 2010 Dec; 90(12):1366-73. PubMed ID: 21076379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-culturing islets with mesenchymal stromal cells using a direct contact configuration is beneficial for transplantation outcome in diabetic mice.
    Rackham CL; Dhadda PK; Chagastelles PC; Simpson SJ; Dattani AA; Bowe JE; Jones PM; King AJ
    Cytotherapy; 2013 Apr; 15(4):449-59. PubMed ID: 23321626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated vascular endothelial growth factor production in islets improves islet graft vascularization.
    Zhang N; Richter A; Suriawinata J; Harbaran S; Altomonte J; Cong L; Zhang H; Song K; Meseck M; Bromberg J; Dong H
    Diabetes; 2004 Apr; 53(4):963-70. PubMed ID: 15047611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel culture technique involving an histone deacetylase inhibitor reduces the marginal islet mass to correct streptozotocin-induced diabetes.
    Shin JS; Min BH; Lim JY; Kim BK; Han HJ; Yoon KH; Kim SJ; Park CG
    Cell Transplant; 2011; 20(9):1321-32. PubMed ID: 21294957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bio-Engineering of Pre-Vascularized Islet Organoids for the Treatment of Type 1 Diabetes.
    Wassmer CH; Lebreton F; Bellofatto K; Perez L; Cottet-Dumoulin D; Andres A; Bosco D; Berney T; Othenin-Girard V; Martinez De Tejada B; Cohen M; Olgasi C; Follenzi A; Berishvili E;
    Transpl Int; 2021; 35():10214. PubMed ID: 35185372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of resveratrol treatment on graft revascularization after islet transplantation in streptozotocin-induced diabetic mice.
    Lee EM; Park I; Lee YJ; You YH; Kim JW; Kim MJ; Ahn YB; Kim P; Ko SH
    Islets; 2018 Jan; 10(1):25-39. PubMed ID: 29333922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced NO production improves early canine islet xenograft function: a role for nitric oxide in islet xenograft primary nonfunction.
    Ketchum RJ; Deng S; Weber M; Jahr H; Brayman KL
    Cell Transplant; 2000; 9(4):453-62. PubMed ID: 11038062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preconditioning regimen with a PKCɛ activator improves islet graft function in a mouse transplant model.
    Hamilton D; Rugg C; Davis N; Kvezereli M; Tafti BA; Busque S; Fontaine M
    Cell Transplant; 2014; 23(7):913-9. PubMed ID: 23562311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 7 releasing particles enhance islet engraftment and improve metabolic control following islet transplantation in mice with diabetes.
    Alwahsh SM; Qutachi O; Starkey Lewis PJ; Bond A; Noble J; Burgoyne P; Morton N; Carter R; Mann J; Ferreira-Gonzalez S; Alvarez-Paino M; Forbes SJ; Shakesheff KM; Forbes S
    Am J Transplant; 2021 Sep; 21(9):2950-2963. PubMed ID: 33428803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RGD-containing elastin-like polypeptide improves islet transplantation outcomes in diabetic mice.
    Lee KM; Kim JH; Choi ES; Kim E; Choi SK; Jeon WB
    Acta Biomater; 2019 Aug; 94():351-360. PubMed ID: 31200117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast populated collagen matrix promotes islet survival and reduces the number of islets required for diabetes reversal.
    Jalili RB; Moeen Rezakhanlou A; Hosseini-Tabatabaei A; Ao Z; Warnock GL; Ghahary A
    J Cell Physiol; 2011 Jul; 226(7):1813-9. PubMed ID: 21506112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting transplant outcomes in diabetic nude mice receiving human, porcine, and nonhuman primate islets: analysis of 335 transplantations.
    Loganathan G; Graham ML; Radosevich DM; Soltani SM; Tiwari M; Anazawa T; Papas KK; Sutherland DE; Hering BJ; Balamurugan AN
    Transplantation; 2013 Jun; 95(12):1439-47. PubMed ID: 23677052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial cell line-derived neurotrophic factor enhances human islet posttransplantation survival.
    Mwangi SM; Usta Y; Shahnavaz N; Joseph I; Avila J; Cano J; Chetty VK; Larsen CP; Sitaraman SV; Srinivasan S
    Transplantation; 2011 Oct; 92(7):745-51. PubMed ID: 21869742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.